Colorectal Cancer Clinical Roundup

News Articles

(MedPage Today) July 12, 2020 - Rectal cancer patients who successfully completed their neoadjuvant chemoradiotherapy regimen saw improved disease-free survival (DFS), a post-hoc analysis of a large phase III trial found.
(MedPage Today) July 8, 2020 - Compared with historical controls, use of image-guidance during surgery led to improved rates of complete resection in locally advanced rectal cancer patients with recurrent disease, a single-center Dutch study found.
(BIDMC) July 7, 2020 - In a new study published in the Journal of Gastrointestinal Surgery, a team of investigators at Beth Israel Deaconess Medical Center (BIDMC) examined the effects of delaying surgery for gastrointestinal cancers.
(Medscape Medical News) July 7, 2020 - Although NTRK fusion genes are rare in gastrointestinal cancers, they should be looked for, inasmuch as responses to the TRK inhibitor entrectinib are robust and durable, say experts.
View all colorectal cancer news


Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Jeffrey A. Meyerhardt, Professor, Medicine, Harvard Medical School, Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute, discuss the progress in CRC presented at ASCO20

OBR Green

June 2020
A panel of three gastrointestinal experts from the City of Hope, the Mayo Clinic, and Duke University Medical Center, led by Charles H. Weaver, MD, shared their perspectives on a key take-away emerging from several high-profile studies at ASCO 2020: less is more when it comes to chemotherapy management in treating colorectal cancer. The panel discussed highlighted data from the virtual scientific program spanning precision medicine, immuno-oncology, and the management of adjuvant colorectal cancer.